Citation Impact
Citing Papers
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2015
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Nutrient sensing and TOR signaling in yeast and mammals
2017
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
2014 Standout
Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality
2015
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
2012 Nature
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Oxygen availability and metabolic reprogramming in cancer
2017
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
2016
Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades
2019
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
2016 StandoutNobel
A view on drug resistance in cancer
2019 StandoutNature
Mechanism and medical implications of mammalian autophagy
2018 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
2013 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
2016
The neuropoietic cytokine family in development, plasticity, disease and injury
2007
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation
2014
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
2014
Insights into the role of IL-32 in cancer
2018
The biology and function of fibroblasts in cancer
2016 Standout
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Oxygen availability and metabolic adaptations
2016
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
2014
MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling
2013
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Antiangiogenic therapy—evolving view based on clinical trial results
2012
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
2012
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
2014
Remodelling the extracellular matrix in development and disease
2014 Standout
Genomic Analysis of Reactive Astrogliosis
2012 Standout
Tumour acidosis: from the passenger to the driver's seat
2017
Common pitfalls in preclinical cancer target validation
2017 StandoutNobel
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer
2015 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
EMT: 2016
2016 Standout
Targeting metastasis
2016
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2022
RNA m6 A modification enzymes shape innate responses to DNA by regulating interferon β
2018
Reading, writing and erasing mRNA methylation
2019 Standout
Gene expression and hypoxia in breast cancer
2011
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
2013
Metastatic colonization by circulating tumour cells
2016 StandoutNature
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
2014
Hepatocellular carcinoma
2022 Standout
Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives
2014
Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation
2013 StandoutNobel
HypoxamiRs and Cancer: From Biology to Targeted Therapy
2013
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
2016 StandoutNobel
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Combination therapy in combating cancer
2017 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
2012
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Targeting Protein–Protein Interactions in the HIF System
2016
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
2013 Standout
Works of Cameron Snell being referenced
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
2011
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
2011
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
2012
Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth
2016
PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer
2015
Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours
2014
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells
2012
Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?
2013
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination
2006